6533b829fe1ef96bd1289f49

RESEARCH PRODUCT

Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).

Ignazio CarrecaFernanda Manuela BellomoGiuseppe BronteM. BurgioD. PiazzaS. RizzoS. RussoL. Balducci

subject

http://hdl.handle.net/10447/12483